In the News: China Biotech FDI; US Lithium Battery Factories; and Chinese Pharma in the UK

May 29, 2024 | BY

Clarence Lee

Western companies are investing in Chinese biotech even amid continued geopolitical tension between China and the West and decreasing appetite for foreign investment in China; Two lithium battery part manufacturers, Capchem and Kedaliplan, plan to build factories in the U.S. to avoid hefty lithium battery tariffs; and Chinese pharma firm Asymchem to take over U.K. Pfizer plant.

Share:

Paulista/Adobe Stock